Sales of Rx/reimbursement adult incontinence struggled in sales over the review period in Germany due to social considerations, however 2020 bucked the trend due to the pandemic. Economic uncertainties coupled with more conservative behaviour of the older populace translated into various attempts to save, including the purchase of adult incontinence products.
Even though incontinence as a topic has become less of a taboo over the review period, many German consumers still refrained from approaching their doctors about it. The reluctance of approaching the subject that is still associated with no longer being in full control of bodily functions has limited the volume sales of incontinence products as a whole, and also Rx/reimbursement purchases throughout the review period, with 2020 being an exception.
As incontinence is expected to gradually gain more acceptance among German consumers as a topic that can at least be discussed with their general practitioners, volume sales of prescription adult incontinence products are expected to see a slowdown in its decline during the latter part of the forecast period. Another limiting factor for volume and value sales of Rx/reimbursement adult incontinence is the restricted availability of these products.
Incontinence products for adults are partially covered by German healthcare providers if a doctor’s prescription is issued. Nevertheless, many insurance companies limit their potential costs further by adding a monthly cap on payments or unit prices.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Germany with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Germany, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page